Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorThe First Affiliated Hospital with Nanjing Medical University

About this trial

ZhenQi FuZheng granules has been used to improve the immune function of human body, protect the bone marrow and adrenal cortex function and promote the recovery of positive function in traditional Chinese medicine care, especially with the immune imbalance diseases like post-surgery, chemotherapy and rhinitis. This project intends to establish AR(allergic rhinitis)specimen library, cell and animal model experiment, combining clinical cohort research with applied basic research, further assess the therapeutic mechanism of ZhenQiFuZheng granules in AR. We assume that ZhenQi FuZheng granules could cause the metabolic omics changes of nasal inflammatory factors and nasal secretions in AR patients, thus improving the type 2 inflammation level of allergic rhinitis.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adult patients (18-65 years).

Patients who visited the Department of Otolaryngology of the First Affiliated Hospital of Nanjing Medical University and are diagnosed as allergic rhinitis .

Disqualifiers

Patients who refused to accept specimen and questionnaire collection.

Patients who had nasal diseases other than allergic rhinitis, such as nasal papilloma and nasal malignant tumor.

Trial design

Design model

Single group

Treatments tested in this trial

  • ZhenQi FuZheng granules (ShiDaiYangGuang)

    Drug

    1 bag at a time, twice a day. Oral orally for 4 weeks.

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Allergic rhinitisExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Rhinoconjunctivitis Quality of Life Questionnaire

Patients were scored by questionnaire before and after treatment, and the change in score before and after treatment was the primary outcome measure

Time frame
12 weeks
2

Visual Analog Score for pain

Patients were scored by questionnaire before and after treatment, and the change in score before and after treatment was the primary outcome measure

Time frame
12 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.